🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareGLP-1 and dental health — March 2026 Page 2

GLP-1 and dental health — March 2026

mike_nyc Thu, Jan 9, 2025 at 12:06 PM 12 replies 1,780 viewsPage 2 of 3
josh_phd_bmore
Member
389
1,678
Jul 2024
Baltimore, MD
Jan 10, 2025 at 1:56 AM#6
mike_nyc said:
Relative and absolute effects need reading together.
mike_nyc said:
...regarding the trial evidence...

I think this is an underappreciated point. To expand on it with some data:

A recent meta-analysis of 12 RCTs (n=8,400) found that the trial evidence was associated with a significant effect size across diverse patient populations[1].

The NNT was 8, which is comparable to antihypertensives for stroke reduction. That's a strong clinical argument for this approach.

30 8NurseKim_ATL, paul_denver, TinaHashiRN and 27 others
Reply Quote Save Share Report
SurmountFan_IN
Member
789
3,456
May 2024
Indianapolis, IN
Jan 10, 2025 at 7:24 AM#7

One thing that is still open after TrialNerd_Beth’s answer:

How would you tell the difference between that and the alternative explanation?

31 9AttorneyGrant, DebRD_ATL, KristenIndy and 28 others
Reply Quote Save Share Report
sophie_paris
Member
212
890
Nov 2024
Paris, FR
Jan 10, 2025 at 12:52 PM#8
josh_phd_bmore said:
mike_nyc said: ...regarding the trial evidence...

Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to:

  1. Point estimate (HR/RR/OR) — center of the diamond
  2. Confidence interval width — precision of the estimate
  3. I² statistic — heterogeneity across studies
  4. Individual study weights — are results driven by one large trial?
  5. Prediction interval — range of plausible true effects in future settings

The the trial evidence meta-analysis shows a pooled RR of 0.79 (95% CI 0.72-0.89), I²=37%. This is a robust and consistent effect.

32 10MariaRD, AussieAnna, BethLabQueen and 29 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Jan 10, 2025 at 6:20 PM#9

Reporting back.

Update — my curve sits below the published mean and the explanation is that the trial arm had support I do not have. That was reassuring rather than otherwise.

33 11pete_RVA, CarlaRPh_TPA, steph_laguna and 30 others
Reply Quote Save Share Report
paul_denver
Member
723
3,234
May 2024
Denver, CO
Jan 11, 2025 at 8:33 PM#10
sophie_paris said:
Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to: Point estimate (HR/RR/OR) —…

Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals. Bayesian approaches provide probability distributions that are more intuitive for clinical decision-making.

For example: "There is a 98.5% probability that semaglutide 2.4mg produces >10% weight loss vs placebo" is more actionable than "RR 3.4, 95% CI 2.8-4.1, p<0.001."

The the trial evidence evidence is strong under both frameworks, but Bayesian analysis better communicates the degree of certainty for individual patient counseling.

39 14kim_atl_prep, sarah_TO, wendy_avl and 36 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register